Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results

[21] Kishimoto Y(2008)Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia Am Heart J. 156 1010-1018

[22] Yoshimoto K(1998)Pathology and pathogenesis of Buerger’s disease Int J Cardiol. 66 S237-S242

[23] Akashi H(2013)Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication Cochrane Database Syst Rev. 23 14-e196

[24] Botham CM(2006)Thromboangiitis obliterans (Buerger’s disease) Orphanet J Rare Dis. 27 e192-296

[25] Bennett WL(2004)Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation Arterioscler Thromb Vasc Biol. 24 288-367

[26] Cooke JP(2012)Development of pluripotent stem cells for vascular therapy Vascul Pharmacol. 56 362-1631

[27] Gu Y(2015)Hypoxia promotes bone marrow-derived mesenchymal stem cell proliferation through apelin/APJ/autophagy pathway Acta Biochim Biophys Sin Shanghai. 47 1624-undefined

[28] Zhang J(2012)Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation Stroke. 43 undefined-undefined

[29] Qi L(undefined)undefined undefined undefined undefined-undefined

[30] Gu Y(undefined)undefined undefined undefined undefined-undefined

[21] Kishimoto Y(2008)Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia Am Heart J. 156 1010-1018

[22] Yoshimoto K(1998)Pathology and pathogenesis of Buerger’s disease Int J Cardiol. 66 S237-S242

[23] Akashi H(2013)Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication Cochrane Database Syst Rev. 23 14-e196

[24] Botham CM(2006)Thromboangiitis obliterans (Buerger’s disease) Orphanet J Rare Dis. 27 e192-296

[25] Bennett WL(2004)Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation Arterioscler Thromb Vasc Biol. 24 288-367

[26] Cooke JP(2012)Development of pluripotent stem cells for vascular therapy Vascul Pharmacol. 56 362-1631

[27] Gu Y(2015)Hypoxia promotes bone marrow-derived mesenchymal stem cell proliferation through apelin/APJ/autophagy pathway Acta Biochim Biophys Sin Shanghai. 47 1624-undefined

[28] Zhang J(2012)Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation Stroke. 43 undefined-undefined

[29] Qi L(undefined)undefined undefined undefined undefined-undefined

[30] Gu Y(undefined)undefined undefined undefined undefined-undefined